精品三级国产精品经典三-精品三级国产一区二区三区四区-精品三级久久久久久久电影-精品三级三级三级三级三级-正在播放一区-正在播放亚洲一区

技術文章您現在的位置:首頁 > 技術文章 > Broadpharm提供可切割和不可切割Linker

Broadpharm提供可切割和不可切割Linker

更新時間:2023-08-28   點擊次數:920次

Antibody-Drug Conjugates (ADCs) are composed of a drug (payload) and antibody (mAbs) that are bound using linkages that are specifically designed to deliver the payload to the intended target environment. ADCs are designed to sparing healthy cells by targeting specific cancer types.

This article expands upon the linker information in the ADC Linker Technology in 2021 article. Specifically, the cleavable and non-cleavable categories of ADC linkers. Cleavable linkers use inherent properties of tumor cells for selective release of payloads from the ADCs. There are three commonly used mechanisms for cleavable linkers; protease-sensitive peptide linkers, acid sensitive hydrazone linkers, and glutathione-sensitive disulfide linkers.

Protease-sensitive cleavable linkers use the dominant proteases found in tumor cell lysosomes for recognition and cleavage of a specific peptide sequence in the linker. A commonly used ADC linker makes use of a valine-citrulline (vc) dipeptide, first discovered by Dubowchik et al., as an intracellular cleavage mechanism by cathepsin B.

diagram of adcetris
Figure 1. Adcetris with enzymatically cleavable val-cit linkage.

Acid-sensitive linkers use a lower pH in the endosomal (pH = 5-6) and lysosomal (pH = 4.8) compartments, in contrast to cytosol (pH = 7.4) to trigger hydrolysis of acid labile groups within a linker such as hydrazone.

Glutathione-sensitive linkers use higher concentrations of intracellular glutathione that in the plasma. This causes disulfide bridges to release the payload upon reduction by glutathione.

Cleavable linkers may also help with destroying cancer cell adjacent to their targets through a process referred to as "bystander effect". The bystander effect occurs when the payload is released near the targeted cancer cell, or a payload diffuses out of one cancer cell and then is absorbed by a second cancer cell.

Non-cleavable linkers only degrade when the anti-body degrades. Release of the payload occurs mainly in the lysosome after internalization of the ADC and degradation of both the antibody and linker. This may be an advantage since it could lead to a lower risk of systemic toxicity. Figure 2 shows an example of Kadcyla, which uses SMCC crosslinker as the non-cleavable linker.

diagram of kadcyla
Figure 2. Kadcyla, shown with the linker in green and the payload in orange, was designed with a non-cleavable linkage.

BroadPharm offers a wide array of different ADC Linkers, PEG Linkers to empower our customer's advanced research worldwide. These compounds feature great aqueous solubility, smart choice of PEG length, and a broad selection of functional groups to choose from.

Journal Reference:

1.Editorial Team, "FDA Grants Accelerated Approval for Sacituzumab Govitecan in Metastatic Triple-negative Breast Cancer", ADC Review (2020)

2.FDA Press Release, "FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma", (2021)

3.Staudacher, Brown, "Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?", Br J Cancer 117, (2017): 1736-1742

    訂購咨詢

    靶點科技(北京)有限公司


靶點科技(北京)有限公司

靶點科技(北京)有限公司

地址:中關村生命科學園北清創意園2-4樓2層

© 2025 版權所有:靶點科技(北京)有限公司  備案號:京ICP備18027329號-2  總訪問量:301967  站點地圖  技術支持:化工儀器網  管理登陸

主站蜘蛛池模板: 亚洲成人美女 | 长腿美女被啪的欲仙欲死视频 | 国产成人免费在线 | 国产一二三区精品 | 国产成人综合高清在线观看 | 欧美久久久久久久一区二区三区 | 日日摸天天摸狠狠摸视频 | 欧美日韩ay在线观看 | 老鸭窝 国产 精品 91 | 亚洲视频三区 | 国产99精品一区二区三区免费 | 国产21区| 成人久久免费视频 | 成人性视频免费网站 | a级毛片在线看日本 | 天天做天天爱夜夜大爽完整 | 91精品自在拍精选久久 | 在线毛片网站 | 国产制服 国产制服一区二区 | 国产亚洲精品久久久久久无 | 国内精品不卡一区二区三区 | 国产一区精品在线观看 | 毛片免费观看成人 | 久久亚洲高清观看 | 成人在线亚洲 | 国产九九精品 | 亚洲人欧洲日韩 | 日韩精品另类天天更新影院 | 亚洲欧美日韩国产精品26u | 国产美女无遮挡软件 | 一级做a免费视频观看网站 一级做a爰 | 久久久久依人综合影院 | 韩国毛片免费看 | 免费中文字幕在线 | 怡红院在线视频全部观看 | 91精品全国免费观看 | 国产激情一区二区三区四区 | 色片在线播放 | 色悠久久久久综合网伊人男男 | 日韩欧美国产一区二区三区 | 久久久青青久久国产精品 |